Methicillin-and gentamicin-resistant strains of Staphylococcus aureus (MGRSA) constitute a major problem in outbreaks of nosocomial infections worldwide (3, 8, 10, 14) . In S. aureus, resistance to the aminoglycoside antibiotic gentamicin (Gmr) and coincident resistance to kanamycin and tobramycin is due to the production of a bifunctional 2"-aminoglycoside phosphotransferase-6'-aminoglycoside [APH(2")-AAC(6')] modifying enzyme (27) . The genetic determinant responsible for this resistance phenotype may be located on the plasmid or chromosome (8, 10, 14, 17, 33, 35) . Plasmid elimination experiments showed that in Dublin MGRSA strains the determinant is invariably chromosomally encoded (8) . In United States isolates the determinant is found on large, structurally related conjugative plasmids (12) . In the majority of Australian isolates the determinant is also plasmid encoded (14, 33) . However, Australian Gmr plasmids are unrelated to their United States counterparts. They are nonconjugative and belong to the Incl incompatibility group (18) . A 4.7-kilobase (kb) transposon, Tn4001, was found on a plasmid specifying gentamicin resistance in Australia (19) . In addition, sequences homologous to that of Tn4001 have been found on aminoglycoside resistance plasmids isolated from United States strains. However, these Gmr determinants have inverted repeats that are 0.75 kb shorter than those of Tn4001 and are not transposable (18) .
MGRSA strains isolated in Dublin hospitals before 1985 were classified into two main groups based on resistance to a range of antimicrobial agents and on plasmid profiles (8) . In addition, the two groups expressed different levels of resistance to gentamicin (MIC, 100 ,ug/ml in group I and 10 ,ug/ml in group II). Atypical group II strains exhibited the same antimicrobial resistance pattern and plasmid profile as group II strains, but the level of Gmr was higher and ranged from 80 to 5,000 ,ug/ml. More recently it has been shown that a new MGRSA strain (group III), most probably introduced from Iraq, has become prevalent in Dublin hospitals (D. Carroll, H. Pomeroy, C. Keane, R. Russell, and D. Coleman, First International Conference of the Hospital Infection Society, abstr. 09 /7, 1987) .
We report here molecular cloning and expression of Gmr determinants from several Dublin MGRSA strains in Escherichia coli and S. aureus. Evidence is presented that a Dublin MGRSA strain contains a functional transposon similar to Tn4001. Southern blot hybridization analyses were used to compare Irish and foreign isolates and showed that group I, II, and III MGRSA strains carry a single copy of the APH(2")-AAC(6') determinant chromosomally.
MATERIALS AND METHODS
Bacterial strains. E. coli K-12 strain C600 (1) Bacteriological media and culture conditions. E. coli strains were grown in L broth (LB) or on L agar (LA) (21) . S. aureus strains were cultured in tryptic soy broth (TSB) or tryptic soy agar (TSA) (Oxoid Ltd., Basingstoke, United Kingdom). Antibiotic susceptibility tests were performed on diagnostic sensitivity agar (DST; Oxoid). MIC determinations were formed as described previously (6) . Antimicrobial agents and susceptibility testing. A disk Assays for aminoglycoside-modifying enzymes. Extracts of diffusion method (29) was used to test susceptibility to the S. aureus strains were prepared as previously described (9) .
following aminoglycosides: gentamicin (15 ,ug) , kanamycin The enzyme assays were performed by the method of Haas (30 IU), tobramycin (10 ,ug) , amikacin (30 ,ug) , sisomicin (10 and Dowding (13) .
,ug), netilmicin (30 pRg), and neomycin (30 IU). Antibiotic
Transduction. The Gmr determinant was transduced from disks were purchased from Diagnostics Pasteur, Marne, S. aureus clinical isolates SA79, SA78, and SA21 into S. France.
aureus RN4220 by the method of Asheshov (4) with exper-MIC determinations. Narrow-interval MICs were deterimental phages C6, C7, and 932, respectively, Findly domined as described previously (7) .
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Concentrations of aminoglycoside antibiotics for MIC determinations were used at the following intervals: 0 to 1.0 pug/ml, 0.2-p.g/ml intervals; 2.0 to 10 pug/ ml, 2-,ug/ml intervals; 10 to 100 pug/ml, 10-,ug/ml intervals; 100 to 1,000 ,ug/ml, 100-,ug/ml intervals; 1,000 to 5,000 ,ug/ml, 100-,ug/ml intervals.
College, Dublin. The determinant was transduced from the clinical isolate SA240 into S. aureus RN1030 by using phage 85 and subsequently into RN4220 by using phage 80. Transductants were selected on TSA supplemented with gentamicin (10 jig/ml).
Molecular cloning. Standard procedures for DNA isolation and molecular cloning were employed (20) . Restriction endonucleases, T4 DNA ligase, DNase I, and DNA polymerase I were purchased from the Boehringer Corporation Ltd., Dublin, and were used according to the manufacturer's instructions.
Molecular cloning in pBR322. Purified total DNA (1 p.g) from S. aureus SA240 and SA79 was cleaved with EcoRI, mixed with EcoRI-cleaved pBR322, ligated, and transformed into E. coli C600. Transformants were selected on agar supplemented with ampicillin (100 [xg/ml) and replica plated onto LA supplemented with kanamycin (10 Fg/ml) and neomycin (10 ,ug/ml). Cloning in S. aureus. HindIll-cleaved pDU1372 and pDU1373 DNA were ligated to HindlIl-cleaved pCW59 DNA. The Tcr determinant of pCW59 is located on a HindlIl fragment and was replaced by the Gmr determinants cloned from pDU1372 or pDU1373. Protoplasts of strain RN4220 were transformed with ligated DNA as described previously (25) , selecting for resistance to chloramphenicol (4 1jg/ml).
Transformants were replica plated onto agar plates supplemented with gentamicin (10 ,ug/ml). The orientation of the Gmr gene with respect to vector sequences was determined by cleavage with NciI, which cuts asymmetrically within the insert.
Isolation of high-level resistant mutants. Overnight cultures of SA240, SA79, and SAF49 were diluted and plated onto TSA supplemented with gentamicin (100 to 5,000 ,g/ml).
DNA hybridization. DNA probes were labeled in vitro by nick translation (26) (10 ,ug/ml) and replica plated onto plates containing chloramphenicol (10 ,ug/ml) at 37°C. Gmr Cms isolates were purified and screened for the absence of plasmid DNA (30) .
Electron microscopy. Homoduplexes were constructed by using 0.5 ,ug of EcoRI-cleaved pDU1370 DNA which was denatured in a solution of 70% formamide-0.3 M NaCl-10 mM Tris-1 mM EDTA (pH 8.5) heated to 750C for 5 min.
The samples were allowed to renature at room temperature for 2 h. Specimens were mounted on celloidin-coated films supported by 200-mesh copper grids by the method of Kleinschmidt (15) . After staining with phosphotungstic acid, the grids were examined in a Hitachi H 7000 scanning transmission electron microscope at a magnification of x 10,000. Plasmid pCW59 (36) DNA was included as a size standard.
RESULTS
Resistance to aminoglycosides expressed by Dublin MGRSA strains. The MIC of aminoglycosides for Dublin MGRSA are given in Table 3 . These values confirm a previous report (8) SA690, which were isolated more recently and were probably introduced by a patient traveling from Iraq, have intermediate levels of resistance to aminoglycosides compared with the group I and group II strains (Table 3) . Group II, atypical group II, and group III strains harbored a plasmidencoded Kmr Ner determinant which accounts for the high level kanamycin resistance in these strains.
Aminoglycoside-modifying activity of clinical isolates. The substrate profiles of aminoglycoside-modifying enzymes expressed by strains SA240 and SA79 are shown in Fig. 1 . The acetylating and phosphorylating activities of both strains were characteristic of an APH(2")-AAC(6') bifunctional enzyme. The neomycin-modifying enzyme of strain SA79 was identified as a 3'-O-aminoglycoside phosphotransferase type III mechanism and was confirmed to be responsible for Kmr Ner in group II, atypical group II, and group III strains by hybridization to a gene-specific probe (34) (unpublished results).
Cloning gentamicin resistance determinants. The Gmr determinants from SA240 (group I) and SA79 (group II) were cloned in pBR322 on EcoRI fragments, forming plasmids pDU1370 and pDU1371, respectively. Both determinants were subsequently subcloned on 2.6-kb HindIII fragments in pBR322, forming plasmids pDU1372 and pDU1373, respectively. The Gmr determinants expressed low levels of resistance to the range of aminoglycosides modified by S. aureus extracts (Table 4) . Southern hybridization was performed with HindIII-cut pDU1372 and pDU1373 DNA by using a 1.5-kb AluI fragment carrying the Gmr determinant cloned from Streptococcus faecalis. A 2.6-kb HindIII fragment hybridized, confirming that the APH(2")-AAC(6') determinant had been cloned in both cases (unpublished data).
Expression of the cloned gentamicin resistance determinants in. S. aureus. The Gmr determinants from pDU1372 and pDU1373 were subcloned in the S. aureus plasmid pCW59, forming pDU1374 and pDU1376, respectively. In strain RN4220 the cloned determinant from a phenotypic group I strain expressed the same level of resistance as the cloned phenotypic group II determinant ( (Table 4 ). The level of expression also appeared to be dependent to some extent on the orientation of the cloned DNA with respect to vector sequences (Table  4) . Southern hybridization analysis of Gmr determinants from clinical isolates. Genomic DNA from MGRSA strains isolated in Dublin, in which Gmr is known to be chromosomally located (8) , was cleaved with EcoRI, an enzyme which does not cut within the prototype Gmr transposon Tn400J (19). Southern hybridization was performed with pSF915A as a probe (Fig. 2) DNA from Dublin MGRSA strains and isolates from other parts of the world were cut with HindIII, an enzyme which cuts within the inverted repeats of Tn4001 (19) . In each strain tested, a 2.6-kb fragment hybridized (Fig. 3) .
Transduction of gentamicin resistance. Gmr determinants from strains SA240, SA79, SA78, and SA21 were transduced into strain RN4220. The transductants were shown by DNA hybridization to have acquired APH(2")-AAC(6') sequences. Interestingly, transductants from each strain expressed the same low level of aminoglycoside resistance in RN4220 (Table 3) . Two transductants from each MGRSA donor strain were analyzed by Southern minant located on the same-sized restriction fragment (data not shown), whereas in the donor strains the marker was associated with different restriction fragments, the sizes of which were characteristic of the MGRSA group (Fig. 2) . Gmr transposon is present in a Dublin MGRSA strain. A shuttle plasmid (pDU1378) was constructed which carried a 9.5-kb EcoRI fragment encoding Gmr isolated from strain SA240. If the Gmr determinant of strain SA240 is located on a transposon similar to Tn4001, it should be present intact in pDU1378 because Tn4001 does not have any EcoRI sites. Plasmid pDU1378 was transferred into S. aureus RN4220, and the plasmid was then cured from ,a population of cells maintained by serial dilution in broth incubated at 43°C.
Five Gmr isolates which had lost Cmr, the marker linked to the replication origin of the vector pDU1378, were shown to lack detectable plasmid DNA. MIC determinations showed that resistance to the range of aminoglycoside antibiotics modified by the APH(2")-AAC(6') bifunctional enzyme was expressed by these derivatives, but the level differed in each strain (Table 4) . To provide direct evidence for transposition of the Gmr determinant intQ the RN4220 chromosome, genomic DNA of the Gmr Cms strains was cut with ClaI. Restriction mapping experiments have shown that this enzyme cleaves within the inverted repeats of Tn4001-like elements (unpublished data). The ClaI-cleaved DNA was probed with nick-translated pDU1370 DNA. In each isolate two unique ClaI fragments were seen among the bands which hybridized (data not shown). These are probably junction fragments between the putative Gmr transposon and chromosomal sequences. The fact that different fragments were seen with each strain is consistent with Gmr being introduced into the chromosome by transposition. Furthermore, the hybridization pattern of parental strain RN4220 remained unchanged in each of the isolates, suggesting that transposition had occurred elsewhere in the chromosome.
Isolation and characterization of Gmr mutants. Spontaneous mutants expressing higher levels of resistance to gentamicin were isolated from wild-type group I, group II, and atypical group II MGRSA strains. In the case of the mutants of SA240 and SAF49 there was a stable concomitant increase in resistance to other aminoglycosides modified by the APH(2")-AAC(6') determinant (Table 3) . Southern hybridization analysis of genomic DNA from mutant strains cleaved with EcoRI (Fig. 4) dosage is probably not an efficient mechanism of increasing resistance, judging by the 10-fold increase in resistance expressed by the cloned Gmr determinant from SA240 linked to pCW59, a plasmid which has a copy number of approximately 120 (35) .
By a process of elimination it can only be inferred that group I, atypical group II, and group III strains have an additional, unlinked resistance mechanism(s) which acts synergistically with the APH(2")-AAC(6') enzymatic mech-anism. Thus each phenotypic group had the Gmr marker in different-sized restriction fragments which were characteristic of the group concerned. Atypical group II strains were the exception; each strain tested had a different-sized hybridizing fragment.
We have tried to seek an explanation for the vastly different levels of resistance expressed by Dublin MGRSA strains. Each type appears to have a single copy of the APH(2")-AAC(6') determinant in the chromosome. When this determinant was transferred by transduction into a laboratory strain of S. aureus, resistance was expressed at the same low level irrespective of the origin of the marker. Similarly, the cloned Gmr determinants from group I and II strains also expressed indistinguishable levels of resistance when introduced into RN4220 on the same vector. This shows that the genetic determinant of elevated Gmr is not linked to the transposon and suggests that a second, unliked mechanism which acts synergistically with the enzymatic mechanism is present in clinical isolates exhibiting high levels of resistance.
It is possible that mutations affecting ribosomal structure or drug transport have been selected. Unfortunately, since the APH(2")-AAC(6') determinants were chromosomal and not plasmid located, it was not possible to study wild-type isolates from which the determinant had been lost.
The five derivatives of RN4220 which had the transposon from strain SA240 inserted at different chromosomal sites expressed resistance to aminoglycosides which varied over a threefold range. However, when the Gmr determinants were transduced from group I and II, atypical group II, and group III donors into a common recipient strain, they were associated with identically sized EcoRV restriction fragments (unpublished data). This suggests that the determinants are located at sites that are basically homologous in the different donor strains but which have acquired restriction site polymorphisms. If this is so, then MGRSA strains which have chromosomally located Gmr determinants may be derived from the same ancestral strain rather than having evolved at different times by independent transposition events.
